Skip to content
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Neurology · Vertebrobasilar Insufficiency

Can a Heart Clot Cause Vertebrobasilar Insufficiency?

At a Glance

A clot from the left side of the heart, often linked to atrial fibrillation, can block the vertebral or basilar arteries and cause a posterior circulation stroke or transient ischemic attack. Doctors use brain and blood-vessel imaging, heart-rhythm monitoring, and echocardiography to find the source.

Emergency Warning: New or worsening sudden dizziness, double vision, loss of balance, trouble walking, or difficulty speaking can be signs of a posterior circulation stroke. Do not wait for testing or attempt to drive yourself. Call emergency services immediately.

Yes, a blood clot that originates in the left side of the heart can travel to the brain and cause a posterior circulation stroke or transient ischemic attack (TIA) [1]. This process is known as a cardioembolism. While vertebrobasilar insufficiency (VBI) often refers to reduced blood flow from narrowed arteries, an embolic clot blocking these same vertebral or basilar arteries can cause similar symptoms, such as dizziness, double vision, or difficulty walking [1][2].

Where Do Heart Clots Come From?

For a clot to travel from the heart to the brain, it generally originates in the heart’s left side or passes through a structural opening. Common cardioembolic sources include:

  • Atrial Fibrillation (A-fib): An irregular, often rapid heart rhythm that causes poor blood flow in the upper chambers of the heart. The sluggish blood can pool and form clots, making A-fib one of the most common causes of cardioembolic strokes [1].
  • Ventricular Thrombus: A blood clot that forms in the lower chambers of the heart (the ventricles), often when the heart muscle is weakened or damaged after a heart attack [3].
  • Mechanical Valves and Tumors: Mechanical heart valves can cause clots to form directly on their surfaces [4]. Rarely, heart tumors like an atrial myxoma can shed tumor material or associated blood clots into the bloodstream [5].
  • Patent Foramen Ovale (PFO): A PFO is a structural hole between the heart’s upper chambers. It does not typically form clots itself. Instead, it can allow a clot originating in the body’s veins (such as in the legs) to cross into the arterial side of the heart and travel to the brain—a process called a paradoxical embolism [6].

How Is It Investigated?

If your symptoms suggest a problem in the back of the brain, emergency stroke evaluation often begins with a non-contrast head CT to quickly rule out bleeding. To determine if a clot came from the heart, your medical team will evaluate your brain, blood vessels, and heart rhythm.

1. Brain and Vascular Imaging

To see whether symptoms are caused by a clot, plaque buildup (atherosclerosis), or a torn blood vessel (dissection), doctors use detailed imaging [2][7].

  • Brain MRI: Highly effective for detecting an acute stroke, though it can occasionally be negative in the very early hours of an event [8].
  • Vascular Scans: A CTA uses iodine contrast dye, while an MRA can often be performed without contrast, to map out the vertebral and basilar arteries and locate blockages [9].

2. Rhythm Monitoring

Because A-fib can be intermittent and “hide” during standard tests, doctors use various devices to monitor your heartbeat over time [10].

  • Standard Tests: A 12-lead ECG is done immediately, often followed by continuous inpatient telemetry monitoring during your hospital stay [10].
  • Extended Outpatient Monitoring: If A-fib is strongly suspected but not found initially, extended monitoring may be recommended. Depending on your risk factors, this can range from a Holter monitor (typically 24 to 48 hours), to wearable patches (days to weeks), or an implantable loop recorder (months to years) [11][12].

3. Echocardiography (Heart Imaging)

Doctors use ultrasound to look for structural issues or clots inside the heart.

  • Transthoracic Echocardiogram (TTE): An ultrasound wand placed on the chest that evaluates overall heart function and can spot some ventricular clots [13].
  • Transesophageal Echocardiogram (TEE): A semi-invasive test where a specialized probe is guided down the throat. It provides a clearer, closer view of the left atrial appendage and heart valves. TEE is usually ordered when seeing these structures clearly is likely to change your treatment plan [13].
  • Advanced Scans: Cardiac MRI or CT may be used in specific cases, such as when doctors strongly suspect a ventricular thrombus that an ultrasound could not clearly confirm [14][3].

How Does the Source Affect Treatment?

Identifying the exact cause of your symptoms is critical because it dictates how future events are prevented. Never start, stop, or change your blood-thinning medications without explicit instructions from your doctor.

  • Antiplatelet Therapy: If your symptoms are caused by atherosclerosis, or if no heart source is found, you will typically be treated with antiplatelet medications (like aspirin or clopidogrel), which keep blood cells from sticking together [15]. Sometimes two antiplatelets are used together for a short period (such as 21 days for minor strokes), followed by a single medication long-term to limit bleeding risk [16][17]. Medical management also includes controlling blood pressure, cholesterol, and diabetes, as well as smoking cessation.
  • Anticoagulation Therapy: If A-fib or a specific cardioembolic clot is confirmed, your doctor may prescribe an anticoagulant (a stronger blood thinner). The exact medication and when you start taking it are highly individualized, depending on the size of the stroke, kidney function, and bleeding risk [18][19]. Anticoagulants carry a higher risk of major bleeding and are generally not prescribed “just in case” an embolic stroke is suspected without a confirmed source [20].

A Crucial Distinction for Heart Valves: For conditions like non-valvular A-fib, direct oral anticoagulants (DOACs) are often preferred [18]. However, DOACs are not used for patients with mechanical heart valves. If you have a mechanical valve, warfarin is the required anticoagulant to prevent clots [4]. Always ensure your care team knows about any heart valves or recent bleeding before a new medication is started.

Common questions in this guide

Can atrial fibrillation send a clot to the part of the brain supplied by the vertebral and basilar arteries?
Yes. Atrial fibrillation can allow blood to pool in the heart’s upper chambers and form a clot that travels to the brain, where it may block a vertebral or basilar artery and cause a posterior circulation stroke or TIA. Narrowed arteries can cause similar symptoms without a heart clot.
What tests can determine whether a posterior circulation event came from my heart?
Doctors may use CT or MRI of the brain and CTA or MRA of the head and neck to look for a stroke or blockage. An ECG, hospital heart monitoring, longer outpatient rhythm monitoring, and an echocardiogram can look for atrial fibrillation, a heart clot, a valve problem, or an opening between the heart’s upper chambers called a PFO. The exact tests depend on your symptoms and initial results.
Could I have atrial fibrillation even if my first ECG is normal?
Yes. Atrial fibrillation can come and go, so a single ECG may not capture it. Doctors may recommend continuous hospital monitoring, a 24- to 48-hour Holter monitor, a wearable patch for days or weeks, or an implantable loop recorder for longer monitoring when suspicion remains.
When is a transesophageal echocardiogram used to look for a heart clot?
A transesophageal echocardiogram uses a probe passed into the esophagus to obtain a closer view of the left atrial appendage and heart valves. It may be recommended when those details could change treatment, especially if a standard chest ultrasound does not provide enough information. Your clinician will weigh the test’s benefits and risks.
Can a patent foramen ovale let a clot reach the brain?
Yes, but a patent foramen ovale, or PFO, usually does not make a clot itself. It can allow a clot from a vein, such as one in the leg, to cross into the arterial circulation and travel to the brain; this is called a paradoxical embolism.
Would finding atrial fibrillation change my blood-thinning treatment?
It may lead your clinician to consider an anticoagulant instead of an antiplatelet medicine, but the choice and timing depend on the stroke’s size, kidney function, and bleeding risk. Direct oral anticoagulants are often used for non-valvular atrial fibrillation, whereas mechanical heart valves require warfarin. Do not start, stop, or change a blood thinner without medical instructions.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on vertebral artery insufficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given my initial brain imaging, what specific cardiac tests do you recommend to rule out a left-sided heart clot or paradoxical embolism?
  2. 2.If my inpatient ECG and standard echocardiogram are normal, what is your threshold for recommending an implantable loop recorder or extended patch monitor to look for hidden atrial fibrillation?
  3. 3.Since I am currently taking an antiplatelet medication, what specific cardiac findings would cause you to switch me to an anticoagulant, given my individual bleeding risk and kidney function?
  4. 4.Is there a specific structural issue, such as a problem with the left atrial appendage or a valve, that would make a transesophageal echocardiogram (TEE) necessary to change my treatment plan?

References

References (20)
  1. 1

    Association of Left Vertebral Artery Hypoplasia with Posterior Circulation Stroke and the Functional Outcome of Patients with Atrial Fibrillation-Related Cardioembolic Stroke.

    Bae JH, Ryu JC, Ha SH, et al.

    AJNR. American journal of neuroradiology 2023; (44(1)):65-69 doi:10.3174/ajnr.A7738.

    PMID: 36521964
  2. 2

    Intravenous Thrombolysis in Posterior Circulation Stroke.

    Dorňák T, Král M, Šaňák D, Kaňovský P

    Frontiers in neurology 2019; (10()):417 doi:10.3389/fneur.2019.00417.

    PMID: 31080436
  3. 3

    Cardiac CT for intra-cardiac thrombus detection in embolic stroke of undetermined source (ESUS).

    Barnea R, Agmon IN, Shafir G, et al.

    European stroke journal 2022; (7(3)):212-220 doi:10.1177/23969873221099692.

    PMID: 36082249
  4. 4

    Early Antithrombotic Therapy in Acute Ischemic Stroke.

    Koga M

    Journal of neuroendovascular therapy 2025; (19(1)) doi:10.5797/jnet.ra.2024-0001.

    PMID: 39958461
  5. 5

    Cutaneous manifestations of infective endocarditis as presenting signs of left atrial myxoma in a patient with acute ischemic stroke: A case report.

    Shen YC, Chang KC, Su JJ

    Medicine 2024; (103(36)):e39088 doi:10.1097/MD.0000000000039088.

    PMID: 39252257
  6. 6

    Diagnosis and Management of Cardioembolic Stroke.

    Yaghi S

    Continuum (Minneapolis, Minn.) 2023; (29(2)):462-485 doi:10.1212/CON.0000000000001217.

    PMID: 37039405
  7. 7

    Bilateral vertebral artery dissection complicated by posterior circulation stroke in a young man: A case report.

    Li Z, Liu J, Wang X, et al.

    Medicine 2020; (99(44)):e22822 doi:10.1097/MD.0000000000022822.

    PMID: 33126321
  8. 8

    Posterior circulation cerebrovascular syndromes: diagnosis and management.

    Schulz UG, Fischer U

    Journal of neurology, neurosurgery, and psychiatry 2017; (88(1)):45-53 doi:10.1136/jnnp-2015-311299.

    PMID: 27071644
  9. 9

    Pathophysiology and Diagnosis of Vertebrobasilar Insufficiency: A Review of the Literature.

    Lima Neto AC, Bittar R, Gattas GS, et al.

    International archives of otorhinolaryngology 2017; (21(3)):302-307 doi:10.1055/s-0036-1593448.

    PMID: 28680502
  10. 10

    Atrial fibrillation detected with outpatient cardiac rhythm monitoring in patients with ischemic stroke or TIA of undetermined cause.

    van der Maten G, Meijs MFL, van der Palen J, et al.

    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2023; (32(12)):107400 doi:10.1016/j.jstrokecerebrovasdis.2023.107400.

    PMID: 37801878
  11. 11

    A Comparison of Atrial Fibrillation Monitoring Strategies After Cryptogenic Stroke (from the Cryptogenic Stroke and Underlying AF Trial).

    Choe WC, Passman RS, Brachmann J, et al.

    The American journal of cardiology 2015; (116(6)):889-93.

    PMID: 26183793
  12. 12

    Atrial Fibrillation Detection and Load: Knowledge Gaps Related to Stroke Prevention.

    Smith EE, Yaghi S, Sposato LA, Fisher M

    Stroke 2024; (55(1)):205-213 doi:10.1161/STROKEAHA.123.043665.

    PMID: 38134250
  13. 13

    Cardiac Imaging After Ischemic Stroke or Transient Ischemic Attack.

    Camen S, Haeusler KG, Schnabel RB

    Current neurology and neuroscience reports 2020; (20(8)):36 doi:10.1007/s11910-020-01053-3.

    PMID: 32607785
  14. 14

    Detection of Left Ventricular Thrombus by Cardiac Magnetic Resonance in Embolic Stroke of Undetermined Source.

    Takasugi J, Yamagami H, Noguchi T, et al.

    Stroke 2017; (48(9)):2434-2440 doi:10.1161/STROKEAHA.117.018263.

    PMID: 28818863
  15. 15

    Medical Management for Secondary Stroke Prevention.

    Kim AS

    Continuum (Minneapolis, Minn.) 2020; (26(2)):435-456 doi:10.1212/CON.0000000000000849.

    PMID: 32224760
  16. 16

    Outcomes Associated With Clopidogrel-Aspirin Use in Minor Stroke or Transient Ischemic Attack: A Pooled Analysis of Clopidogrel in High-Risk Patients With Acute Non-Disabling Cerebrovascular Events (CHANCE) and Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trials.

    Pan Y, Elm JJ, Li H, et al.

    JAMA neurology 2019; (76(12)):1466-1473 doi:10.1001/jamaneurol.2019.2531.

    PMID: 31424481
  17. 17

    Navigating Antiplatelet Treatment Options for Stroke: Evidence-Based and Pragmatic Strategies.

    Moustafa B, Testai FD

    Current neurology and neuroscience reports 2022; (22(11)):789-802 doi:10.1007/s11910-022-01237-z.

    PMID: 36227497
  18. 18

    Antithrombotic treatment for secondary prevention of stroke and other thromboembolic events in patients with stroke or transient ischemic attack and non-valvular atrial fibrillation: A European Stroke Organisation guideline.

    Klijn CJ, Paciaroni M, Berge E, et al.

    European stroke journal 2019; (4(3)):198-223 doi:10.1177/2396987319841187.

    PMID: 31984228
  19. 19

    Early Rivaroxaban Use After Cardioembolic Stroke May Not Result in Hemorrhagic Transformation: A Prospective Magnetic Resonance Imaging Study.

    Gioia LC, Kate M, Sivakumar L, et al.

    Stroke 2016; (47(7)):1917-9 doi:10.1161/STROKEAHA.116.013491.

    PMID: 27222524
  20. 20

    Direct Oral Anticoagulants Versus Aspirin for Stroke Prevention After Embolic Stroke of Undetermined Source: An Updated Meta-Analysis of Randomized Controlled Trials.

    Pirera E, D'Anna L, Di Raimondo D, Tuttolomondo A

    Journal of clinical medicine 2024; (13(22)) doi:10.3390/jcm13226730.

    PMID: 39597873

This page is for informational purposes only and does not constitute medical advice. Sudden dizziness, double vision, trouble walking, or other stroke warning signs require emergency evaluation rather than waiting for outpatient testing.